Skip to main content

Melissa D. Cooper

09/22/2014
New Orleans—Many new type 2 diabetes and type 2 diabetes-related treatments are taking patient-centered approaches. The American Diabetes Association and the European Association for the Study of Diabetes advocate personalized treatment....
New Orleans—Many new type 2 diabetes and type 2 diabetes-related treatments are taking patient-centered approaches. The American Diabetes Association and the European Association for the Study of Diabetes advocate personalized treatment....
New Orleans—Many new type 2...
09/22/2014
First Report Managed Care
Department
04/22/2014
Common complications of acute coronary syndrome (ACS) are atrial fibrillation (AF) and heart failure.
Common complications of acute coronary syndrome (ACS) are atrial fibrillation (AF) and heart failure.
Common complications of acute...
04/22/2014
First Report Managed Care
Newsfeed
02/02/2016
Patient behavior can be critical to health outcomes, but how can these individuals’ behavior be influenced to improve health care outcomes? Virtual health assistants, Thomas Morrow, MD, chief medical officer, Next IT, said during the second...
Patient behavior can be critical to health outcomes, but how can these individuals’ behavior be influenced to improve health care outcomes? Virtual health assistants, Thomas Morrow, MD, chief medical officer, Next IT, said during the second...
Patient behavior can be critical...
02/02/2016
First Report Managed Care
09/22/2014
Many diets have been studied for the prevention and treatment of cardiometabolic risk factors, but not generally the Mediterranean or the DASH diets.
Many diets have been studied for the prevention and treatment of cardiometabolic risk factors, but not generally the Mediterranean or the DASH diets.
Many diets have been studied for...
09/22/2014
First Report Managed Care
LTC Bulletin Board
06/01/2015
Amgen announced that the FDA approved Corlanor (ivabradine) for the treatment of stable heart failure (HF).
Amgen announced that the FDA approved Corlanor (ivabradine) for the treatment of stable heart failure (HF).
Amgen announced that the FDA...
06/01/2015
Annals of Long-Term Care
12/16/2015
Determining the vale of a drug may require less data than you realize
Determining the vale of a drug may require less data than you realize
Determining the vale of a drug...
12/16/2015
First Report Managed Care
News Connection
04/22/2014
A recent study showed statin therapy decreased relative cardiovascular risk by 25% [Database Syst Rev. 2013;1:CD004816]. In 2013, the American College of Cardiology and the American Heart Association (ACC/AHA) made recommendations for...
A recent study showed statin therapy decreased relative cardiovascular risk by 25% [Database Syst Rev. 2013;1:CD004816]. In 2013, the American College of Cardiology and the American Heart Association (ACC/AHA) made recommendations for...
A recent study showed statin...
04/22/2014
First Report Managed Care
06/19/2014
There are an estimated 15 million Medicare beneficiaries using retiree health benefit plans as supplemental coverage. An additional >2 million pre-retirees are also using retiree health benefit plans as a primary source of coverage, making...
There are an estimated 15 million Medicare beneficiaries using retiree health benefit plans as supplemental coverage. An additional >2 million pre-retirees are also using retiree health benefit plans as a primary source of coverage, making...
There are an estimated 15...
06/19/2014
First Report Managed Care
Conference Insider
06/18/2015
An increasing number of aging adults and disabled individuals are enrolling in Medicaid due to the recent decision by many states to expand Medicaid coverage.
An increasing number of aging adults and disabled individuals are enrolling in Medicaid due to the recent decision by many states to expand Medicaid coverage.
An increasing number of...
06/18/2015
First Report Managed Care
12/16/2015
Specialty Pharma: The Good, the Bad, and the Challenging The rising cost of specialty pharmaceuticals is a critical issue among managed care professionals.  
Specialty Pharma: The Good, the Bad, and the Challenging The rising cost of specialty pharmaceuticals is a critical issue among managed care professionals.  
Specialty Pharma: The Good, the...
12/16/2015
First Report Managed Care